Advertisement

Topics

Molecular Detection Inc. Company Profile

20:51 EST 21st January 2019 | BioPortfolio

Molecular Detection Inc. (MDI), a US-based company with offices in Wayne, PA, Tunbridge Wells, UK and Jerusalem, Israel, is developing and commercializing a portfolio of "sample-to-answer" Detect-Ready(TM) molecular diagnostic tests for the detection of infectious diseases. The company's first product is a ready-to-use rapid detection hospital-based screening test for MRSA. These staph infections represent a growing problem to the healthcare system. Successful MRSA control efforts rely on screening potential carriers to prevent the spread of the disease. The Detect-Ready(TM) MRSA test provides increased accuracy, faster time to results and more efficient utilization of hospital resources compared to other MRSA diagnostic products. It is currently available in the UK, Germany, Ireland, Switzerland, Austria and Spain, with additional launches expected in the coming months. MDI's real-time PCR tests are based on novel patent-pending technologies for differential diagnosis and room-temperature stabilization. For more information, visit www.detect-ready.com.


News Articles [874 Associated News Articles listed on BioPortfolio]

Performance of Blood Culture Molecular Panels Evaluated

High accuracy of direct identification of pathogens from positive blood culture molecular panels is imperative, particularly for the detection of...

FDA clears DiaSorin Molecular's group B strep assay

The FDA has granted DiaSorin Molecular clearance to market its Simplexa GBS Direct assay for qualitative detection of group B -More- 

Molecular profiling of precancerous lung lesions could lead to early detection and new treatments

The world's first genetic sequencing of precancerous lung lesions could pave the way for very early detection and new treatments, reports a new study led by UCL researchers.

Will accelerated Laser PCR benefit time critical molecular tests?

Revolutionising the fundamentals of scientific and medical research. GNA Biosolutions is a Munich-based High-tech engineering firm which has developed instruments, OEM modules, and assays for ultra-fa...

Detection of high-risk carbapenem-resistant Klebsiella pneumoniae and Enterobacter cloacae isolates using volatile molecular profiles

DIACARTA introduces new QClamp assays for detection of cancer gene mutations

DIACARTA Inc., a precision molecular diagnostics company headquartered in Richmond, California, today announced that it is launching a new suite of CE-IVD marked highly sensitive hydrolysis probe base...

New PET probe could improve detection of primary and metastatic melanoma

(Society of Nuclear Medicine and Molecular Imaging) A new nuclear medicine method for detecting malignant melanoma, one of the most aggressive skin cancers, has been successfully tested for the first ...

USDA Food Safety and Inspection Service Chooses 3M for E. coli, Salmonella and Listeria Testing

3M Food Safety has been awarded a contract from the U.S. Department of Agriculture Food Safety and Inspection Service (USDA FSIS) for pathogen detection instruments and kits. The ...

PubMed Articles [2707 Associated PubMed Articles listed on BioPortfolio]

Comparison of five methods of extraction of Staphylococcus aureus DNA for molecular detection by PCR.

Molecular techniques for the detection of pathogens have been shown to be effective diagnostic tools with high sensitivity and short turnaround times.

In-site synthesis molecular imprinting NbO -based photoelectrochemical sensor for bisphenol A detection.

In this work, a photoelectrochemical (PEC) sensor based on inorganic surface molecular imprinting NbO (MI-NbO) for detection of bisphenol A (BPA) had been developed. In the PEC sensor, MI-NbO material...

Modification of nanocrystalline TiO coatings with molecularly imprinted TiO for uric acid recognition.

Combining the surface modification and molecular imprinting technique, a novel piezoelectric sensing platform with excellent molecular recognition capability was established for the detection of uric ...

Sero-molecular detection, multi-locus genotyping, and clinical manifestations of ocular toxoplasmosis in patients in northwest Iran.

Our goal was to use molecular techniques to verify and characterise clinical diagnoses of ocular toxoplasmosis. Clinical cases were evaluated against IgM and IgG Toxoplasma antibodies, and IgG avidity...

Selection of Molecular Markers for the Estimation of Somaclonal Variation.

Tissue culture for plant micropropagation is known to be a source of genetic changes termed "somaclonal variation". This protocol is designed to help in the selection of one or more types of molecular...

Clinical Trials [3166 Associated Clinical Trials listed on BioPortfolio]

Assessment of Bmi-1 on Protein and Molecular Levels in Oral Dysplasia and Squamous Cell Carcinoma: A Diagnostic Study

The aim of the current study is to assess the validation of Bmi-1 detection at both protein and molecular levels in oral epithelial dysplasia and oral squamous cell carcinoma as a biomarke...

Detection of Circulating Biomarkers of Immunogenic Cell Death

In this exploratory study, the investigators will investigate if markers (molecular and immunological) of ICD or anti-tumor immunity (exosomal or molecular) can be detected in the serum of...

Molecular Assessment of Drug Resistance Markers in Asymptomatic Malaria Cases and Malaria Antibody Kinetic

Detection of the drug resistance molecular markers for falciparum and vivax in Longitudinal follow-up samples collected in Shwegyin Township, Bago Region that is Artemisinin Resistance Con...

Molecular Diagnosis of Respiratory Viral Infections on Sputum From Cystic Fibrosis Patients

The main objective of this project is to evaluate the agreement between nasopharyngeal and sputum specimens in terms of detection of viral infection in Cystic Fibrosis (CF) participants.Th...

Fluorescence Bronchoscopy and Molecular Characterization of Abnormal Bronchial Lesions: Novel Approaches for Early Detection of Lung Cancer in High Risk Patients

Despite intensive research efforts, there are still no simple and effective screening tools to detect early lung cancer. The majority of newly diagnosed patients have higher stage, often ...

Companies [1342 Associated Companies listed on BioPortfolio]

Mobidiag Ltd.

Mobidiag is a commercial stage, fast growing molecular diagnostics company whose affordable, widely applicable and robust technology makes the power of molecular diagnostics avail...

Xenomics

Xenomics, Inc. is the developer of next-generation molecular diagnostics products that address important health problems worldwide. Our mission is to apply our proprietary transrenal DNA test platfor...

Molecular Detection Inc.

Molecular Detection Inc. (MDI), a US-based company with offices in Wayne, PA, Tunbridge Wells, UK and Jerusalem, Israel, is developing and commercializing a portfolio of "sample-to-answer" Detect-Read...

BioHelix Corporation

BioHelix’s is a molecular diagnostic company focused on improving the quality of healthcare through the development of simple molecular diagnostic tests for the near patient ...

Exact Sciences Corp.

Exact Sciences Corp. is a molecular diagnostics company focused on colorectal cancer. The company has exclusive intellectual property protecting its non-invasive, molecular screen...

More Information about "Molecular Detection Inc." on BioPortfolio

We have published hundreds of Molecular Detection Inc. news stories on BioPortfolio along with dozens of Molecular Detection Inc. Clinical Trials and PubMed Articles about Molecular Detection Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Molecular Detection Inc. Companies in our database. You can also find out about relevant Molecular Detection Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Molecular diagnostics
Molecular diagnostics is a technique used to analyse biological markers in the genome and proteome—the individual's genetic code and how their cells express their genes as proteins—by applying molecular biology to medical testing. The tec...

Public Health
Alternative Medicine Cleft Palate Complementary & Alternative Medicine Congenital Diseases Dentistry Ear Nose & Throat Food Safety Geriatrics Healthcare Hearing Medical Devices MRSA Muscular Dyst...

MRSA (methicillin-resistant Staphylococcus aureus)
MRSA (methicillin-resistant Staphylococcus aureus) is a family of bacteria with resistance to one or more major antibiotics. There are currently 17 different strains of MRSA. Two particular strains, EMRSA15 and EMRSA16  account for 96% of MRSA blood...


Corporate Database Quicklinks



Searches Linking to this Company Record